» Articles » PMID: 15625306

Lipopolysaccharide Induces 5-lipoxygenase-activating Protein Gene Expression in THP-1 Cells Via a NF-kappaB and C/EBP-mediated Mechanism

Overview
Specialties Cell Biology
Physiology
Date 2004 Dec 31
PMID 15625306
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

We examined induced expression of the 5-lipoxygenase-activating protein (FLAP), which is critical for leukotriene synthesis in mononuclear phagocytes. Prolonged exposure to the bacterial component, lipopolysaccharide (LPS), increased FLAP gene transcription, mRNA expression, and protein expression in the human monocyte-like THP-1 cell line. Activation and inhibition of the NF-kappaB pathway modulated LPS induction of FLAP gene expression. An NF-kappaB-mediated mechanism of action was supported by overexpression of dominant-negative IkappaBalpha and p50/p65 proteins. EMSA/supershift and DNase I footprint analyses revealed that p50 binds to an NF-kappaB site located in the proximal FLAP promoter, while chromatin immunoprecipitation assays demonstrated that LPS induced binding of p50 but not of p65. Moreover, EMSA/supershift analyses demonstrated that LPS induced time-dependent binding of THP-1 nuclear extracts (containing p50) to this promoter region. Mutation of the NF-kappaB site decreased basal promoter activity and abolished the p50- and p65-associated induction. EMSA/supershift analyses also demonstrated that LPS induced binding of THP-1 nuclear extracts [containing CCAAT/enhancer binding protein (C/EBP)-alpha, -delta, and -epsilon] to a C/EBP site located adjacent to the NF-kappaB site in the FLAP promoter. We conclude that LPS enhances FLAP gene expression via both NF-kappaB- and C/EBP-mediated transcriptional mechanisms in mononuclear phagocytes.

Citing Articles

Basic biology and roles of CEBPD in cardiovascular disease.

Li T, Lin S, Zhu Y, Ye D, Rong X, Wang L Cell Death Discov. 2025; 11(1):102.

PMID: 40087290 DOI: 10.1038/s41420-025-02357-4.


Sea Anemone Kunitz Peptide HCIQ2c1 Reduces Histamine-, Lipopolysaccharide-, and Carrageenan-Induced Inflammation via the Suppression of Pro-Inflammatory Mediators.

Kvetkina A, Klimovich A, Deriavko Y, Pislyagin E, Menchinskaya E, Bystritskaya E Int J Mol Sci. 2025; 26(1.

PMID: 39796283 PMC: 11721031. DOI: 10.3390/ijms26010431.


Bacteroides Fragilis in the gut microbiomes of Alzheimer's disease activates microglia and triggers pathogenesis in neuronal C/EBPβ transgenic mice.

Xia Y, Xiao Y, Wang Z, Liu X, Alam A, Haran J Nat Commun. 2023; 14(1):5471.

PMID: 37673907 PMC: 10482867. DOI: 10.1038/s41467-023-41283-w.


Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation.

Chen C, Liao J, Xia Y, Liu X, Jones R, Haran J Gut. 2022; 71(11):2233-2252.

PMID: 35017199 PMC: 10720732. DOI: 10.1136/gutjnl-2021-326269.


Mechanistic insight on the role of leukotriene receptors in ischemic-reperfusion injury.

Khan H, Gupta A, Singh T, Kaur A Pharmacol Rep. 2021; 73(5):1240-1254.

PMID: 33818747 DOI: 10.1007/s43440-021-00258-8.